This study demonstrates that CD5 expression in CTCL is largely dependent on lesion type, with malignant CD4 T cells from patch/plaque MF lesions showing elevated CD5 transcript levels compared to malignant CD4 T cells from MF tumor lesions and healthy control CD4 T cells. This evidence concerns the gene CD4 and mycosis fungoides.